The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Fernanda Borges da Silva, Lorena Lobo de Figueiredo-Pontes, Maria Isabel Ayrosa Madeira, Luisa Correa de Araujo Koury, Ana Silvia Gouvea de Lima, Priscila Santos Scheucher, Juan Luiz Coelho-Silva, Katia Borgia Barbosa Pagnano, Ronald Pallota, Maria de Lourdes Chauffaille, Marcos Roberto Pedron...

The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Fernanda Borges da Silva, Lorena Lobo de Figueiredo-Pontes, Maria Isabel Ayrosa Madeira, Luisa Correa de Araujo Koury, Ana Silvia Gouvea de Lima, Priscila Santos Scheucher, Juan Luiz Coelho-Silva, Katia Borgia Barbosa Pagnano, Ronald Pallota, Maria de Lourdes Chauffaille, Marcos Roberto Pedron...

										

The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Fernanda Borges da Silva, Lorena Lobo de Figueiredo-Pontes, Maria Isabel Ayrosa Madeira, Luisa Correa de Araujo Koury, Ana Silvia Gouvea de Lima, Priscila Santos Scheucher, Juan Luiz Coelho-Silva, Katia Borgia Barbosa Pagnano, Ronald Pallota, Maria de Lourdes Chauffaille, Marcos Roberto Pedron...

    Fontes

    Blood advances

    Vol. 1, supl 1 (Dec., 2017), p. 86-89